Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Mankind Pharma Ltd.
NSE: MANKIND
|
BSE: 543904
|
ISIN: INE634S01028
|
Industry: Pharmaceuticals
Analyst Downgrade
|
Expensive Performer
2395.8000
31.70
(
1.34
%)
NSE
Jun 18, 2026
11:35 AM
25.45% Gain from 52W Low
Volume:
160.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Mankind Pharma Ltd.
26 Mar 2025
Analyst Downgrade
2395.80
1.34%
MANKIND PHARMA LIMITED
Accumulate:
Mankind Pharma Ltd.
by
Geojit BNP Paribas
Target: 2691
Geojit BNP Paribas
Number of FII/FPI investors decreased from 575 to 568 in Mar 2026 qtr
More from Mankind Pharma Ltd.
Recommended
Market trades lower, Man Industries secures orders worth Rs 1,000 crore
Trendlyne Marketwatch |
18 Jun 2026, 11:31AM
India Inc tests the tolerance of consumers for higher prices
The Baseline |
18 Jun 2026, 10:54AM
Stocks vs FD: has the extra risk been worth it?
The Baseline |
17 Jun 2026, 10:31PM